

Author: Petrou Stavros Dakin Helen Abangma Giselle Benge Sarah Williamson Ian
Publisher: Blackwell Publishing
ISSN: 1098-3015
Source: Value in Health, Vol.13, Iss.5, 2010-08, pp. : 543-551
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Recent Developments in the Treatment of Otitis Media with Effusion
By Mandel Ellen M. Casselbrant Margaretha L.
Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. :


Cost-benefit or cost-utility analysis?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. :




Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan
PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. :